Mode
Text Size
Log in / Sign up
N/A N=98 Screening

Screening, Brief Intervention, and Referral to Treatment in Primary Care

Diabetes Mellitus, Type 2 · Substance-related Disorders

Enrolled (actual)
98
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Drug Use Status and Frequency — 2.00; 0.03; 0.02; 0.60 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Referral to Treatment (Behavioral); Brief Intervention (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Jun 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Drug Use Status and Frequency
2.00; 0.03; 0.02; 0.60; 0.00; 0.00
PRIMARY
Cigarette Smoking Status and Nicotine Dependence
1.50; 2.91; 0.00; 1.60; 2.78; 0.00
PRIMARY
Alcohol Use Status
1.60; 0.76; 0.00; 0.00; 0.44; 0.00
PRIMARY
Percentage of Participants Who Reported Substance Use at 6 Month
30.0; 0.0; 0.0; 0.0; 0.0; 0.0
PRIMARY
Treatment for Drug Use or Alcohol
20.0; 0.0; 0.0; 20.0; 0.0; 0.0

Summary

This add-on study of providing tobacco, alcohol and other drug screening, brief intervention and referral for treatment to a primary care high risk diabetic population leverages the existing research resources of a funded parent project "Duke University CMS Innovation Award Southeastern Diabetes initiative (PI: Robert M. Califf, MD)" to explore the feasibility of implementing Screening for substance use, Brief Intervention, and Referral to Treatment services in Primary Care (SBIRT-PC) and to examine the effects of substance use status on diabetes health care outcomes. This pilot study also examines the feasibility of the CTN's common data element algorithms of SBIRT for illicit and nonmedical drug use in the primary care setting.

Eligibility Criteria

Inclusion Criteria

  • Adults ≥ 18 years
  • Diagnosis of Type 2 diabetes
  • Reside in Durham County, NC, or the neighboring areas and receive the majority of their healthcare in the county
  • Referral from the primary care clinician or patient's medical home if one has been designated
  • Have capacity to make decisions

Exclusion Criteria

  • Lack capacity to make decisions and do not have a surrogate with authority to make health care decisions.
  • Have a terminal illness with a life expectancy of 6 months or less
  • Diagnosis of Type 1 diabetes or gestational diabetes
  • Currently pregnant
  • Unable to comply with study requirement
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01966432). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search